Guys,
That quote in the article is one reason why I highly recommend people start doing their research on EDXC. This is a company that is currently doing clinical trials with CBD and has a capsule version that they are utilizing. They have a website where they are already engaging in significant sales of a variety of CBD products and my feeling is that there's a good chance that the DEA will reschedule CBD versus the entire plant, which will put Endexx (EDXC) in quite the enviable position and could trigger a serious explosion in price per share.
They just released news about their clinical trials a few days ago. I believe the CEO is positioning the company to best capture market share once the DEA renders it's decision (which could come in the next week to two weeks). I believe they are being set up as a buyout target for big Pharma once the DEA gives the green light.
Another Company to strongly consider getting into immediately (although not a cannabis ticker) is PXYN. I bring this one up for a few reasons… They just updated their shareholder letter which indicates that they are coming out of their quiet. period within the next few weeks, and the share price has already begun responding today. But more importantly, they produce and distribute a product of pharmaceutical grade quality that treats pain without the use of opioids. Given the DEA's new focus on the opioid crisis in this country, companies such as PXYN producing a proprietary painkilling product that has already exhibited effectiveness in the marketplace with significant sales, stand to gain profound price increases over the coming months and years. Current price there is only half a penny.
Best of luck to all!
Neo
